Anti-E2F1 monoclonal antibody

Pre-made anti-E2F1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to E2F1/E2F1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T57059-Ab-1/ GM-Tg-hg-T57059-Ab-2Anti-Human E2F1 monoclonal antibodyHuman
GM-Tg-rg-T57059-Ab-1/ GM-Tg-rg-T57059-Ab-2Anti-Rat E2F1 monoclonal antibodyRat
GM-Tg-mg-T57059-Ab-1/ GM-Tg-mg-T57059-Ab-2Anti-Mouse E2F1 monoclonal antibodyMouse
GM-Tg-cynog-T57059-Ab-1/ GM-Tg-cynog-T57059-Ab-2Anti-Cynomolgus/ Rhesus macaque E2F1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T57059-Ab-1/ GM-Tg-felg-T57059-Ab-2Anti-Feline E2F1 monoclonal antibodyFeline
GM-Tg-cang-T57059-Ab-1/ GM-Tg-cang-T57059-Ab-2Anti-Canine E2F1 monoclonal antibodyCanine
GM-Tg-bovg-T57059-Ab-1/ GM-Tg-bovg-T57059-Ab-2Anti-Bovine E2F1 monoclonal antibodyBovine
GM-Tg-equg-T57059-Ab-1/ GM-Tg-equg-T57059-Ab-2Anti-Equine E2F1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T57059-Ab-1/ GM-Tg-hg-T57059-Ab-2; GM-Tg-rg-T57059-Ab-1/ GM-Tg-rg-T57059-Ab-2;
GM-Tg-mg-T57059-Ab-1/ GM-Tg-mg-T57059-Ab-2; GM-Tg-cynog-T57059-Ab-1/ GM-Tg-cynog-T57059-Ab-2;
GM-Tg-felg-T57059-Ab-1/ GM-Tg-felg-T57059-Ab-2; GM-Tg-cang-T57059-Ab-1/ GM-Tg-cang-T57059-Ab-2;
GM-Tg-bovg-T57059-Ab-1/ GM-Tg-bovg-T57059-Ab-2; GM-Tg-equg-T57059-Ab-1/ GM-Tg-equg-T57059-Ab-2
Products NameAnti-E2F1 monoclonal antibody
Formatmab
Target NameE2F1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-E2F1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T57059-Ag-1Recombinant multi-species E2F1/ E2F-1/ RBAP1 protein
    ORF Viral VectorvGMAD000181human E2F1 Adenovirus particle
    ORF Viral VectorpGMAD000181human E2F1 Adenovirus plasmid


    Target information

    Target IDGM-T57059
    Target NameE2F1
    Gene ID1869,13555,399489,714126,485839,101098454,535369,100069192
    Gene Symbol and SynonymsE2F-1,E2F1,mKIAA4009,RBAP1,RBBP3,RBP3,Tg(Wnt1-cre)2Sor
    Uniprot AccessionQ01094,O09139
    Uniprot Entry NameE2F1_HUMAN,E2F1_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000101412
    Target ClassificationTumor-associated antigen (TAA)

    The target: E2F1, gene name: E2F1, also named as E2F-1, RBAP1, RBBP3, RBP3. The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain.  This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.